ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,524Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 117

$1.57M Total Retail Price of All Prescriptions

Rank: 11 out of 117

1,634 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 1,634 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

21% of this provider’s 1,634 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 17,241 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 985 881 1 2
LEVOTHYROXINE SODIUM 791 686 2 1
HYDROCODONE-ACETAMINOPHEN 713 569 S3 3 3
METFORMIN HCL 612 495 4 15
SERTRALINE HCL 562 506 5 16
FUROSEMIDE 540 493 6 4
NEXIUM 538 470 7 36
OMEPRAZOLE 522 448 8 9
AMLODIPINE BESYLATE 510 450 9 5
LISINOPRIL 494 393 10 6
METOPROLOL SUCCINATE 478 406 11 17
ALENDRONATE SODIUM 371 359 12 26
METOPROLOL TARTRATE 341 248 13 8
DIOVAN 304 281 14 38
AZITHROMYCIN 297 240 15 64
ZOLPIDEM TARTRATE 275 209 16 24
TAMSULOSIN HCL 269 254 17 31
ATORVASTATIN CALCIUM 254 202 18 21
DIOVAN HCT 214 191 19 115
LOSARTAN POTASSIUM 200 158 20 32
LANTUS 193 164 21 25
FAMOTIDINE 192 155 22 49
CLOPIDOGREL 185 174 23 30
CEFUROXIME 184 167 24 144
HYDRALAZINE HCL 180 170 25 50
CIPROFLOXACIN HCL 173 145 26 56
JANUMET 169 143 27 202
GABAPENTIN 164 109 28 12
GLYBURIDE-METFORMIN HCL 164 147 R 28 126
PRAVASTATIN SODIUM 163 125 30 33
QUETIAPINE FUMARATE 154 127 31 20
POTASSIUM CHLORIDE 142 124 32 11
JANUVIA 141 130 33 88
TRAZODONE HCL 141 128 33 23
AMOX TR-POTASSIUM CLAVULANATE 140 118 35 102
CARVEDILOL 137 117 36 22
ATENOLOL 134 106 37 42
PLAVIX 130 115 38 41
MUPIROCIN 130 101 38 113
ISOSORBIDE MONONITRATE ER 128 118 40 48
VOLTAREN 127 110 41 210
WARFARIN SODIUM 124 106 42 13
LEVOFLOXACIN 122 95 43 55
PREDNISONE 120 96 44 47
HYDROCHLOROTHIAZIDE 117 88 45 28
INSULIN SYRINGE 115 80 46 138
CARBIDOPA-LEVODOPA 115 110 46 53
AMLODIPINE BESYLATE-BENAZEPRIL 115 109 46 114
LYRICA 115 74 46 73
LANTUS SOLOSTAR 115 95 46 188
CYMBALTA 114 102 51 27
MIRTAZAPINE 114 112 51 14
LEVEMIR FLEXPEN 113 84 53 155
PEN NEEDLE 106 81 54 195
BUMETANIDE 97 85 55 127
NAMENDA 97 97 55 7
EXFORGE 95 83 57 237
BACLOFEN 90 57 58 74
PANTOPRAZOLE SODIUM 89 83 59 39
CRESTOR 89 69 59 58
LOSARTAN-HYDROCHLOROTHIAZIDE 88 81 61 106
METOCLOPRAMIDE HCL 87 78 62 91
FLUTICASONE PROPIONATE 86 73 63 44
MELOXICAM 84 80 64 70
MECLIZINE HCL 79 72 65 202
LIPITOR 74 55 66 131
ALLOPURINOL 73 71 67 66
ACTOS 73 59 67 161
ACTOPLUS MET 72 62 69 276
SPIRONOLACTONE 71 61 70 69
LOVAZA 70 50 71 164
SEROQUEL 70 58 71 57
ESCITALOPRAM OXALATE 68 61 73 29
DIGOXIN 66 66 74 45
ENALAPRIL MALEATE 64 44 75 72
LACTULOSE 61 47 76 65
ACTONEL 58 51 77 171
AVODART 58 54 77 187
ROPINIROLE HCL 57 56 79 89
BENAZEPRIL HCL 56 43 80 142
DETROL LA 55 48 81 146
DONEPEZIL HCL 54 54 82 10
BENICAR 53 50 83 211
HYDROCORTISONE 52 41 84 268
RANITIDINE HCL 52 47 84 43
VESICARE 51 51 86 223
VENLAFAXINE HCL ER 50 35 87 78
AMIODARONE HCL 50 32 87 98
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 30, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.